Clinical trial
Study of Enfuvirtide in HIV-Positive Subjects
NCT00086710 · Trimeris, Industry · Completed
Key facts
| NCT number | NCT00086710 |
|---|---|
| Title | Study of Enfuvirtide in HIV-Positive Subjects |
| Official title | An Open-label, Randomized, Cross-over Study in HIV-Positive Subjects to Determine and Compare the Single-dose Pharmacokinetics of Enfuvirtide after a Single 90 mg SC Administration |
| Lead sponsor | Trimeris, Industry |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, AIDS |
| Intervention type | Drug |
| Interventions | Fuzeon |
| Enrollment | 26 |
| First posted | Jul 13, 2004 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: